FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anna Marina Liberati

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Lorenzo Falchi; Lucia Ferranti; Marco Gunnellini; Anna Marina Liberati
High-dose methotrexate and temozolomide associated with intrathecal liposomal cytarabine for the treatment of primary or secondary central nervous system lymphoma: a preliminary experience.
Luigi Rigacci; Delia Rota-Scalabrini; Sergio Storti; Francesco Zaja; Pier Luigi Zinzani; Anna Marina Liberati; Enrico Orciuolo; Caterina Patti; Andrea Piccin; Benedetta Puccini; Monica Balzarotti; Velia Bongarzoni; Alberto Bosi; Andrea Carpaneto; Sergio Cortelazzo; Alfonso D'Arco; R Freilone; Gianluca Gaidano; Marco Gobbi; Emilio Iannitto
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).
Esther Natalie Oliva; Fabrizio Pane; Andrea Piccin; Enrico Maria Pogliani; Umberto Recine; Emanuele Angelucci; Emma Cacciola; Rossella Cacciola; Nicola Cascavilla; Renato Fanin; Giuseppe Fioritoni; Marco Gobbi; Luigi Gugliotta; Mauro Krampera; Anna Marina Liberati; Maria Gabriella Mazzucconi; Enrica Morra; Sante Tura
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anna Marina Liberati (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Lorenzo Falchi; Lucia Ferranti; Marco Gunnellini; Anna Marina Liberati
High-dose methotrexate and temozolomide associated with intrathecal liposomal cytarabine for the treatment of primary or secondary central nervous system lymphoma: a preliminary experience.
Clinical neurology and neurosurgery 2012;114(10):1376-8.
2012: Luigi Rigacci; Delia Rota-Scalabrini; Sergio Storti; Francesco Zaja; Pier Luigi Zinzani; Anna Marina Liberati; Enrico Orciuolo; Caterina Patti; Andrea Piccin; Benedetta Puccini; Monica Balzarotti; Velia Bongarzoni; Alberto Bosi; Andrea Carpaneto; Sergio Cortelazzo; Alfonso D'Arco; R Freilone; Gianluca Gaidano; Marco Gobbi; Emilio Iannitto
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).
Annals of hematology 2012;91(7):1013-22.
2012: Esther Natalie Oliva; Fabrizio Pane; Andrea Piccin; Enrico Maria Pogliani; Umberto Recine; Emanuele Angelucci; Emma Cacciola; Rossella Cacciola; Nicola Cascavilla; Renato Fanin; Giuseppe Fioritoni; Marco Gobbi; Luigi Gugliotta; Mauro Krampera; Anna Marina Liberati; Maria Gabriella Mazzucconi; Enrica Morra; Sante Tura
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study.
Annals of hematology 2012;91(4):527-32.
2012: Francesco Merli; Maurizio Musso; Giuseppe Rossi; Flavia Salvi; Caterina Stelitano; Alessandra Tucci; Alice Di Rocco; Isabel Alvarez; Annalisa Arcari; Luca Baldini; Annalisa Chiappella; Alberto Fragasso; Paolo G Gobbi; Fiorella Ilariucci; Anna Marina Liberati; stefano luminari; Caterina Mammi; Luigi Marcheselli; Patrizio Mazza; Massimo Federico
Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi.
Leukemia & lymphoma 2012;53(4):581-8.
2012: Roberta Martiniani; Alessandra Lombardo; Valentina Di Loreto; Chiara Di Sano; Anna Marina Liberati
Biological activity of lenalidomide and its underlying therapeutic effects in multiple myeloma.
Advances in hematology 2012;2012():842945.
2012: Marco Gunnellini; Stefano Coaccioli; Rita Emili; Anna Marina Liberati
The role of autologous stem cell transplantation in the treatment of diffuse large B-cell lymphoma.
Advances in hematology 2012;2012():195484.
2011: Luigi Gugliotta; Alessandra Iurlo; Anna Marina Liberati; Monia Lunghi; Vincenzo Martinelli; Emma Cacciola; Rossella R Cacciola; Anna Candoni; Rosanna Ciancia; Katia Codeluppi; Monica Crugnola; Alberto Grossi; Fausto Palmieri; Ivana Pierri; Potito Rosario Scalzulli; Giorgina Specchia; Alessia Tieghi; Giovanni Tortorella; Emilio Usala; Alessandro M Vannucchi; Nicola Vianelli; Maria Gabriella Mazzucconi
Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia.
Leukemia research 2011;35(12):1557-63.
2011: Simonetta Viviani; Francesco Zaja; Pier Luigi Zinzani; Delia Rota Scalabrini; Gianni Bonadonna; Valeria Bonfante; Ercole Brusamolino; Andrea Gallamini; ALESSANDRO MASSIMO GIANNI; Manuel Gotti; Alessandro Levis; Anna Marina Liberati; Enrico M Pogliani; Patrizia Pregno; Alessandro Pulsoni; Alessandro Rambaldi; Andrea Rossi; Giorgina Specchia; Pinuccia Valagussa; Umberto Vitolo
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
The New England journal of medicine 2011;365(3):203-12.
2011: Francesca Gay; Alessandra Larocca; Pierre Wijermans; Federica Cavallo; Davide Rossi; Ron Schaafsma; Mariella Genuardi; Alessandra Romano; Anna Marina Liberati; Agostina Siniscalchi; Maria Teresa Petrucci; Chiara Nozzoli; Francesca Patriarca; Massimo Offidani; Roberto Ria; Paola Omedè; Benedetto Bruno; Roberto Passera; Pellegrino Musto; Mario Boccadoro; Pieter Sonneveld; Antonio Palumbo
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients.
Blood 2011;117(11):3025-31.
2010: Sara Bringhen; Alessandra Larocca; Davide Rossi; Maide Cavalli; Mariella Genuardi; Roberto Ria; Silvia Gentili; Francesca Patriarca; Chiara Nozzoli; Anna Levi; Tommasina Guglielmelli; Giulia Benevolo; Vincenzo Callea; Vincenzo Rizzo; Clotilde Cangialosi; Pellegrino Musto; Luca De Rosa; Anna Marina Liberati; Mariella Grasso; Antonietta Falcone; Andrea Evangelista; Michele Cavo; Gianluca Gaidano; Mario Boccadoro; Antonio Palumbo
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.
Blood 2010;116(23):4745-53.
2010: Massimo Offidani; Pietro Leoni; Laura Corvatta; Claudia Polloni; Silvia Gentili; Anna Marina Liberati; Stefano Pulini; Alessandro Gozzetti; Stelvio Ballanti; Chiara Nozzoli; Antonio Palumbo
Outcome and toxicity in the modern era of new drugs for multiple myeloma: a reappraisal for comparison with future investigational trials.
Clinical lymphoma, myeloma & leukemia 2010;10(5):353-60.
2010: Lorenzo Falchi; Giovanna Rege-Cambrin; Carmen Fava; Emilio Donti; Debora Luzi; Emilia Giugliano; Marta Gubbiotti; Monica Schippa; Anna Marina Liberati
Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution.
Cancer genetics and cytogenetics 2010;199(2):139-42.
2010: marco ladetto; Gloria Pagliano; Simone Ferrero; Federica Cavallo; Daniela Drandi; Loredana Santo; Claudia Crippa; Luca De Rosa; Patrizia Pregno; Mariella Grasso; Anna Marina Liberati; Tommaso Caravita; Francesco Pisani; Tommasina Guglielmelli; Vincenzo Callea; Pellegrino Musto; Clotilde Cangialosi; Roberto Passera; Mario Boccadoro; Antonio Palumbo
Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(12):2077-84.
2010: Antonio Palumbo; Sara Bringhen; Benedetto Bruno; Antonietta Pia Falcone; Anna Marina Liberati; Mariella Grasso; Roberto Ria; Francesco Pisani; Clotilde Cangialosi; Tommaso Caravita; Anna Levi; Giovanna Meloni; Andrea Nozza; Patrizia Pregno; Attilio Gabbas; Vincenzo Callea; Manuela Rizzo; Luciana Annino; Valerio De Stefano; Pellegrino Musto; Ileana Baldi; Federica Cavallo; Maria Teresa Petrucci; Massimo Massaia; Mario Boccadoro
Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study.
Blood 2010;115(10):1873-9.
2010: Lorenzo Falchi; Marco Gunnellini; Laura Franco; Patrizia Ferrazza; Stefano Ascani; Anna Marina Liberati
Rapid and sustained response of an intra- and extracranial large cell lymphoma mass to liposomal intrathecal Ara-C and R-MegaCEOP systemic chemotherapy.
Journal of neuro-oncology 2010;97(1):53-7.
2010: Antonio Palumbo; Francesca Gay; Patrizia Falco; Claudia Crippa; Vittorio Montefusco; Francesca Patriarca; Fausto Rossini; Simona Caltagirone; Giulia Benevolo; Norbert Pescosta; Tommasina Guglielmelli; Sara Bringhen; Massimo Offidani; Nicola Giuliani; Maria Teresa Petrucci; Pellegrino Musto; Anna Marina Liberati; Giuseppe Rossi; Paolo Corradini; Mario Boccadoro
Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(5):800-7.
2009: Umberto Vitolo; Annalisa Chiappella; Emanuele Angelucci; Giuseppe Rossi; Anna Marina Liberati; Maria Giuseppina Cabras; Barbara Botto; Giovannino Ciccone; Gianluca Gaidano; Lorenzo Falchi; Roberto Freilone; Domenico Novero; Lorella Orsucci; Vincenzo Pavone; Enrico Pogliani; Delia Rota-Scalabrini; Fabrizio Salvi; Anna Tonso; Alessandra Tucci; Alessandro Levis
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study.
Haematologica 2009;94(9):1250-8.
2008: Antonio Palumbo; Sara Bringhen; Anna Marina Liberati; Tommaso Caravita; Antonietta Falcone; Vincenzo Callea; Marco Montanaro; Roberto Ria; Antonio Capaldi; Renato Zambello; Giulia Benevolo; Daniele Derudas; Fausto Dore; Federica Cavallo; Francesca Gay; Patrizia Falco; Giovannino Ciccone; Pellegrino Musto; Michele Cavo; Mario Boccadoro
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.
Blood 2008;112(8):3107-14.
2008: Patrizia Falco; Federica Cavallo; Alessandra Larocca; Anna Marina Liberati; Pellegrino Musto; Mario Boccadoro; Antonio Palumbo
Lenalidomide and its role in the management of multiple myeloma.
Expert review of anticancer therapy 2008;8(6):865-74.
2008: marco ladetto; Federica De Marco; Fabio Benedetti; Umberto Vitolo; Caterina Patti; Alessandro Rambaldi; Alessandro Pulsoni; Maurizio Musso; Anna Marina Liberati; Attilio Olivieri; Andrea Gallamini; Enrico Pogliani; Vincenzo Callea; Francesco Di Raimondo; Vincenzo Pavone; Alessandra Tucci; Sergio Cortelazzo; Alessandro Levis; Mario Boccadoro; Ignazio Majolino; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI; Roberto Passera; Paolo Corradini; Corrado Tarella; Delia Rota Scalabrini
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage.
Blood 2008;111(8):4004-13.
2008: Francesca Palandri; Ilaria Iacobucci; giovanni martinelli; Marilina Amabile; Angela Poerio; Nicoletta Testoni; Simona Soverini; Fausto Castagnetti; Antonio de Vivo; Massimo Breccia; Giorgina Specchia; Elisabetta Abruzzese; Bruno Martino; Daniela Cilloni; Giuseppe Saglio; Fabrizio Pane; Anna Marina Liberati; Gianantonio Rosti; Michele Baccarani
Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(1):106-11.
2007: Lorenzo Falchi; Daniela Capello; Barbara Palumbo; Annamaria Rauco; Rita Emili; Michele Cianciulli; Roberta Pace; Vincenzo Capparella; Fabrizio Liberati; Anna Marina Liberati
A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy.
European journal of haematology 2007;79(5):455-61.
2007: Franck Morschhauser; Timothy M Illidge; Damien Huglo; Giovanni Martinelli; Giovanni Paganelli; Pier Luigi Zinzani; Simon Rule; Anna Marina Liberati; Noël Milpied; Georg Hess; Harald Stein; Joachim Kalmus; Robert Marcus
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation.
Blood 2007;110(1):54-8.
2007: Francesco Merli; Marilena Bertini; stefano luminari; Ruggero Mozzana; Barbara Botto; Anna Marina Liberati; Luca Baldini; G Cabras; Francesco Di Vito; Lorella Orsucci; E Naglieri; Giuseppe Polimeno; Luigi Marcheselli; Elsa Pennese; Umberto Vitolo; Massimo Federico; Eugenio Gallo
Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.
Leukemia & lymphoma 2007;48(2):367-73.
2006: Emilio Donti; Alfonso Zaccaria; Alessandra Bassetti; Giovanna Venti; Barbara Giannini; Paolo Prontera; Erika Bianchi; Anna Valenti; Giuseppe Saglio; Anna Marina Liberati
Occurrence of the same chromosome abnormalities in Ph+ and Ph- cells in chronic myeloid leukaemia. Evidence of a secondary origin of the Ph chromosome?
British journal of haematology 2006;135(2):265-6.
2006: Antonio Palumbo; Sara Bringhen; Tommaso Caravita; Emanuela Merla; Vincenzo Capparella; Vincenzo Callea; Clotilde Cangialosi; Mariella Grasso; Fausto Rossini; Monica Galli; Lucio Catalano; Elena Zamagni; Maria Teresa Petrucci; Valerio De Stefano; Manuela Ceccarelli; Maria Teresa Ambrosini; Ilaria Avonto; Patrizia Falco; Giovannino Ciccone; Anna Marina Liberati; Pellegrino Musto; Mario Boccadoro
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.
Lancet 2006;367(9513):825-31.
2006: Nicola Di Renzo; Maura Brugiatelli; Antonella Montanini; Maria Luigia Vigliotti; Giulia Cervetti; Anna Marina Liberati; stefano luminari; Pierangelo Spedini; Gianfranco Giglio; Massimo Federico
Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi.
Leukemia & lymphoma 2006;47(3):473-9.
2005: Barbara Palumbo; Silvio Sivolella; Isabella Palumbo; Anna Marina Liberati; Renato Palumbo
67Ga-SPECT/CT with a hybrid system in the clinical management of lymphoma.
European journal of nuclear medicine and molecular imaging 2005;32(9):1011-7.
2005: Umberto Vitolo; Anna Marina Liberati; Maria Giuseppina Cabras; Massimo Federico; Emanuele Angelucci; Luca Baldini; Carola Boccomini; Maura Brugiatelli; Roberta Calvi; Giovannino Ciccone; Angelo Genua; Giorgio Lambertenghi Deliliers; Alessandro Levis; Guido Parvis; Enzo Pavone; Fabrizio Salvi; Marco Sborgia; Eugenio Gallo
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial.
Haematologica 2005;90(6):793-801.
2004: Antonio Palumbo; Sara Bringhen; Maria Teresa Petrucci; Pellegrino Musto; Fausto Rossini; Martina Nunzi; Vito Michele Lauta; Cesare Bergonzi; Anna Barbui; Tommaso Caravita; Antonio Capaldi; Patrizia Pregno; Tommasina Guglielmelli; Mariella Grasso; Vincenzo Callea; Alessandra Bertola; Federica Cavallo; Patrizia Falco; Cecilia Rus; Massimo Massaia; Franco Mandelli; Angelo Michele Carella; Enrico Pogliani; Anna Marina Liberati; Franco Dammacco; Giovannino Ciccone; Mario Boccadoro
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.
Blood 2004;104(10):3052-7.
2004: Stefano Ascani; Philip Thomas Went; Anna Marina Liberati; Pier Paolo Piccaluga; Pier Luigi Zinzani; Stefano A Pileri
Difficult diagnostic and therapeutic cases: CASE 1. true thymic hyperplasia in a patient treated for T-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(5):953-4.
2003: Luigi Rigacci; Massimo Federico; Maurizio Martelli; Pier Luigi Zinzani; Luigi Cavanna; Giampiero Bellesi; Francesco Merli; Renato Alterini; Maria Teresa Petrucci; Monica Tani; Anna Marina Liberati; Umberto Vitolo; Vincenzo Pavone; Antonio Cuneo; Teodoro Chisesib; Maura Brugiatelli
The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases.
Leukemia & lymphoma 2003;44(11):1911-7.
2002: Srdan Verstovsek; Hui Lin; Andrew Lamb; Giuseppe Saglio; Daniela De Micheli; Fabrizio Pane; Guillermo Garcia-Manero; Mariano Intrieri; Bruno Rotoli; Francesco Salvatore; Jie Qiang Guo; Moshe Talpaz; Giorgina Specchia; Giovanni Pizzolo; Anna Marina Liberati; Jorge Cortes; Robert C Quackenbush; Ralph B Arlinghaus
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course.
Cancer 2002;94(9):2416-25.
2001: Roberto P Revoltella; Leopoldo Laricchia-Robbio; S Moscato; Fabrizio Vinante; A Fasciani; Anna Marina Liberati; Gigliola Reato; Robin Foa
Naturally-occurring anti-G-CSF antibodies produced by human cord blood B-cell lines infected with Epstein-Barr virus.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(3):161-71.
2000: Roberto P Revoltella; Leopoldo Laricchia-Robbio; Anna Marina Liberati; Gigliola Reato; Robin Foa; A Funaro; Fabrizio Vinante; G Pizzolo
Antibodies binding granulocyte-macrophage colony stimulating factor produced by cord blood-derived B cell lines immortalized by Epstein-Barr virus in vitro.
Cellular immunology 2000;204(2):114-27.
1997: Roberto P Revoltella; Leopoldo Laricchia-Robbio; S Moscato; Angelo Genua; Anna Marina Liberati
Natural and therapy-induced anti-GM-CSF and anti-G-CSF antibodies in human serum.
Leukemia & lymphoma 1997;26 Suppl 1():29-34.
1997: Leopoldo Laricchia-Robbio; S Moscato; Angelo Genua; Anna Marina Liberati; Roberto P Revoltella
Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serum.
Journal of cellular physiology 1997;173(2):219-26.
1997: Marilena Bertini; R Freilone; Barbara Botto; Roberta Calvi; Andrea Gallamini; A M Gatti; Anna Marina Liberati; Vittorio Meneghini; Ester Orlandi; Lorella Orsucci; Michele Pizzuti; Fabrizio Salvi; Giuseppe Todeschini; Umberto Vitolo; Delia Rota Scalabrini; Luigi Resegotti
Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin).
Haematologica 1997;82(3):309-13.
1997: Umberto Vitolo; S Cortellazzo; Anna Marina Liberati; R Freilone; Michele Falda; Marilena Bertini; Barbara Botto; S Cinieri; Alessandro Levis; Franco Locatelli; Elisabetta Lovisone; Filippo Marmont; Michele Pizzuti; A Rossi; P Viero; T Barbui; F Grignani; Luigi Resegotti
Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):491-8.
1996: A Ferrajoli; M Fizzotti; Anna Marina Liberati; Francesco Grignani
Chronic myelogenous leukemia: an update on the biological findings and therapeutic approaches.
Critical reviews in oncology/hematology 1996;22(3):151-74.
1995: A Ferrajoli; Anna Marina Liberati; P Caricchi; Emilio Donti; Enrica Morra; Mario Lazzarino; A R Betti; Paolo Bernasconi; G Saglio
Interferon-alpha plus low-dose cytosine arabinoside in advanced phase chronic myelogenous leukaemia patients.
European journal of haematology 1995;55(3):184-8.
1994: Anna Marina Liberati; M A Horisberger; P Garofani; V De Angelis; A Ferrajoli; F Di Clemente; P Caricchi; D Adiuto; L Fedeli; Barbara Palumbo
Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia.
Journal of interferon research 1994;14(6):349-55.
1994: Giuseppe Calabrese; Liborio Stuppia; P G Franchi; R Peila; Elisena Morizio; Anna Marina Liberati; A Spadano; R Di Lorenzo; Emilio Donti; A Antonucci
Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis.
Cancer genetics and cytogenetics 1994;78(2):153-9.
1994: Anna Marina Liberati; V De Angelis; M Fizzotti; M Schippa; M Cecchini; D Adiuto; F Di Clemente; L Palmisano; E Micozzi; M Zuccaccia
Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.
Cancer immunology, immunotherapy : CII 1994;38(5):323-31.
1994: Anna Marina Liberati; P Garofani; V De Angelis; F Di Clemente; M Horisberger; M Cecchini; A R Betti; L Palmisano; S Astolfi; A Nastari
Double-blind randomized phase I study on the clinical tolerance and pharmacodynamics of natural and recombinant interferon-beta given intravenously.
Journal of interferon research 1994;14(2):61-9.
1994: Anna Marina Liberati; Emilio Donti; C Rosso; Francesco Lo Coco; F Dore; S Pardini; S Cocco; M Addis; G Saglio
Repeated PCR in CML during IFN-alpha therapy.
European journal of haematology 1994;52(3):152-5.
1993: Enrica Morra; Giuliana Alimena; Mario Lazzarino; Anna Marina Liberati; Enrico Montefusco; Paolo Bernasconi; M Mancini; Emilio Donti; S Merante; P Caricchi
Evolving approaches with interferon alfa in chronic myelogenous leukemia.
Seminars in hematology 1993;30(3 Suppl 3):26-7.
1992: Anna Marina Liberati; M A Horisberger; L Palmisano; S Astolfi; A Nastari; S Mechati; A Villa; S Mancini; S Arzano; F Grignani
Double-blind randomized phase I study on the clinical tolerance and biological effects of natural and recombinant interferon-beta.
Journal of interferon research 1992;12(5):329-36.
1992: Emilio Donti; A Ferrajoli; G V Donti; M Senatore; C Ardisia; G Saglio; Anna Marina Liberati
Effect of IFN alpha therapy on secondary Ph1-positive clones.
British journal of haematology 1992;81(3):451-3.
1991: Anna Marina Liberati; M Schippa; M G Portuesi; M Grazia Proietti; V De Angelis; A Ferrajoli; S Cinieri; F Di Clemente; L Palmisano; P Berruto
IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.
Haematologica 1991;76(5):375-82.
1991: M C Pagliacci; Giuliana Pelicci; M Schippa; Anna Marina Liberati; Ildo Nicoletti
Does interferon-beta therapy induce thyroid autoimmune phenomena?
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1991;23(4):196-7.
1991: Anna Marina Liberati; S Cinieri; M Schippa; F Di Clemente; S Filippo; Francesco Grignani
GM-CSF: clinical trials in non-Hodgkin's lymphoma patients with chemotherapy induced leucopenia.
Leukemia 1991;5 Suppl 1():119-22.
1991: Enrica Morra; Giuliana Alimena; Mario Lazzarino; Anna Marina Liberati; Enrico Montefusco; Paolo Bernasconi; M Mancini; Emilio Donti; S Merante; Ferdinando Dianzani
Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemia.
European journal of cancer (Oxford, England : 1990) 1991;27 Suppl 4():S14-7.
1991: Anna Marina Liberati; M Horisberger; M Schippa; F Di Clemente; M Fizzotti; S Filippo; M G Proietti; S Arzano; P Berruto; L Palmisano
Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.
Cancer immunology, immunotherapy : CII 1991;34(2):115-22.
1990: Anna Marina Liberati; S Biagini; G Perticoni; S Ricci; P D'Alessandro; M Senatore; S Cinieri
Electrophysiological and neuropsychological functions in patients treated with interferon-beta.
Journal of interferon research 1990;10(6):613-9.
1990: Anna Marina Liberati; S Cinieri; M G Senatore; M G Portuesi; V De Angelis; F Di Clemente; M Schippa; A Ferrajoli; S Arzano; P Berruto
Phase I-II trial on natural beta interferon in chemoresistant and relapsing multiple myeloma.
Haematologica 1990;75(5):436-42.
1990: Enrica Morra; Giuliana Alimena; Mario Lazzarino; Anna Marina Liberati; Enrico Montefusco; D Inverardi; Paolo Bernasconi; M Mancini; Emilio Donti; M Senatore
[Interferon in the treatment of Philadelphia-positive chronic myeloid leukemia].
Haematologica 1990;75 Suppl 4():33-40.
1990: Giuliana Alimena; Enrica Morra; Mario Lazzarino; Anna Marina Liberati; Enrico Montefusco; D Inverardi; Paolo Bernasconi; Marco Mancini; Emilio Donti; F Grignani
Interferon alpha-2b as therapy for patients with Ph'-positive chronic myelogenous leukemia.
European journal of haematology. Supplementum 1990;52():25-8.
1990: Anna Marina Liberati; M Fizzotti; F Di Clemente; M Senatore; P Berruto; Brunangelo Falini; Massimo F Martelli; Francesco Grignani
Response to intermediate and standard doses of IFN-beta in hairy-cell leukaemia.
Leukemia research 1990;14(9):779-84.
1989: Anna Marina Liberati; B Biscottini; M Fizzotti; M Schippa; V De Angelis; M Senatore; O Vittori; L Teggia; R Natali; L Palmisano
A phase I study of human natural interferon-beta in cancer patients.
Journal of interferon research 1989;9(3):339-48.
1989: Anna Marina Liberati; S Cinieri; M Fizzotti; M Schippa; Stefano Ascani; V De Angelis; M Senatore; L Palmisano
Modulation of NK activity by thymic hormones: in vitro effects of thymostimulin.
Medical oncology and tumor pharmacotherapy 1989;6(1):45-52.
1988: Anna Marina Liberati; M Fizzotti; M G Proietti; R Di Marzio; M Schippa; B Biscottini; M Senatore; P Berruto; S Canali; G Peretti
Biochemical host response to interferon-beta.
Journal of interferon research 1988;8(6):765-77.
1988: Giuliana Alimena; Enrica Morra; Mario Lazzarino; Anna Marina Liberati; Enrico Montefusco; D Inverardi; Paolo Bernasconi; Marco Mancini; Emilio Donti; Francesco Grignani
Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration.
Blood 1988;72(2):642-7.
1988: Francesco Grignani; M Fizzotti; Anna Marina Liberati; A Tabilio; M Schippa; F Falzetti; B Biscottini; E Cristallini; F Grignani
Myelomonocytic-associated antigens in a case of genotypically, phenotypically and functionally B-cell lymphoma.
Haematologica 1988;73(3):173-7.
1988: Giuliana Alimena; Enrica Morra; Mario Lazzarino; Anna Marina Liberati; Enrico Montefusco; D Inveradi; Paolo Bernasconi; Marco Mancini; Francesco Grignani; Carlo Bernasconi
Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A).
Cancer treatment reviews 1988;15 Suppl A():21-6.
1988: Anna Marina Liberati; Enzo Ballatori; M Fizzotti; M Schippa; L Cini; S Cinieri; M G Proietti; R Di Marzio; M Senatore; Francesco Grignani
A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission.
Cancer immunology, immunotherapy : CII 1988;26(1):87-93.
1987: Anna Marina Liberati; Enzo Ballatori; M Fizzotti; M Schippa; M G Proietti; R Di Marzio; A Pecci; L Biscetti; R Sbarretti; L Cini
Immunologic profile in patients with Hodgkin's disease in complete remission.
Cancer 1987;59(11):1906-13.
1986: Anna Marina Liberati; Adolfo Puxeddu; A Allegra; B Biscottini; N Curzi; P Andreani; E Cristallini; Francesco Grignani
Generalized sarcoid-type reaction associated with non-Hodgkin's lymphoma.
Haematologica 1986;71(3):225-8.
1985: Anna Marina Liberati; B Biscottini; A Barbati; A Pecci; Stefano Coaccioli; P Andreani; P Bertoni; Adolfo Puxeddu; Francesco Grignani
Rare immunological presentation in B-cell chronic lymphocytic leukaemia.
Haematologica 1985;70(4):345-9.
1985: Anna Marina Liberati; Adolfo Puxeddu; B Biscottini; A Allegra; M Pennacchi; P Bertoni; A Pecci; Enzo Ballatori; Francesco Grignani
Preliminary observation on the clinical tolerance of interferon-beta in cancer patients.
Tumori 1985;71(1):45-9.
1985: Anna Marina Liberati; M Brugia; B S Edwards; P Bertoni; Enzo Ballatori; Adolfo Puxeddu; Francesco Grignani
Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remission.
Cancer immunology, immunotherapy : CII 1985;19(2):136-41.
1983: Anna Marina Liberati; Francesco Di Costanzo; F Buzzi; G Fatati; B Biscottini; Enzo Ballatori; R Falchi; Francesco Grignani
5-Fluorouracil, vincristine and hydroxyurea combination chemotherapy in metastatic colorectal cancer.
Tumori 1983;69(5):485-7.
1983: Anna Marina Liberati; Francesco Di Costanzo; C Anasetti; F Buzzi; R Falchi; Francesco Grignani
Humoral nonparathyroid hypercalcemia without evidence of bone involvement.
Tumori 1983;69(3):223-6.
1982: P Rambotti; Anna Marina Liberati; A Velardi; Enzo Ballatori; M F Martelli; F Grignani; S Davis
Cell membrane markers and phytohemagglutinin reactivity of circulating lymphocytes from chronic myelocytic leukemia patients.
Cancer 1982;49(4):708-13.